Advisory Services Network, LLC Allogene Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$2.28 - $3.5 $2,188 - $3,360	960 New	960 $3,000
Q4 2022 Feb 13, 2023	BUY	$5.62 - $11.11 $831 - $1,644	148 New	148 $0
Q3 2021 Nov 05, 2021	SELL	$21.01 - $27.64 $81,939 - $107,796	-3,900 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$23.49 - $35.8 $91,611 - $139,620	3,900 New	3,900 $102,000
Q4 2020 Feb 09, 2021	SELL	$25.24 - $43.45 $126 - $217	-5 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$32.38 - $44.96 $161 - $224	5 New	5 $0

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.